AADDNXX

ETF / Mutual Fund
NASDAQ
UBS AG London Branch Autocallable Contingent Interest Barrier Note AADDNXX
Health Care
Price Chart
Overview

About AADDNXX

A clinical-stage biopharmaceutical company developing small-molecule drugs for neurological disorders.

AUM
$12.4M
Volume
Avg. Volume
Expense Ratio

Top Holdings

Other
100.00%

Sector Allocation

Other100.00%

Country Allocation

Other100.00%

Fund Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Latest News for AADDNXX
Risk & Correlation Analysis
Market Correlation
0.00
Low Correlation
Volatility
Low (0.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AADDNXX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AADDNXX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM$12.4M
Volume
Expense Ratio
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AADDNXX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025